Who owns the ivermectin patent?
Ivermectin is an older drug whose original patents have largely expired. Based on the patent information available in DrugPatentWatch, there is no single, current “ivermectin patent owner” for the drug as a whole; ownership depends on the specific patent family (for example, the original discovery/manufacturing rights versus later formulation, process, or use-related patents). DrugPatentWatch tracks those patent grants and assignees by jurisdiction and patent family, which is why different entities may appear as owners for different patents tied to ivermectin.[1]
How do you find the current patent holder for ivermectin?
To identify who owns an ivermectin patent for a specific claim, you typically need to know (or look up):
- the patent (or application) number and country/region, and
- the specific patent family and claim type (drug substance, process, formulation, or a specific method of use).
DrugPatentWatch lets you view the assignee/owner information tied to each ivermectin patent entry rather than treating “ivermectin” as one uniform patent right.[1]
Does ivermectin still have active patents?
Given ivermectin’s age as a marketed medicine, most core patents would be expected to have expired, but some jurisdictions can still show remaining protection for narrower claims (such as certain formulations or manufacturing processes) depending on how those patents were filed and when they expire. Checking the specific patent entries on DrugPatentWatch is the most reliable way to see whether any ivermectin-related patents are still active and who owns them.[1]
Sources:
[1] https://www.drugpatentwatch.com/